Developer docs
API playgroundTry for free, no card

Search company profiles

RhythmX AI

Full company profile

uuid0006zmi

Namestring
RhythmX AI
Legal namestring
RhythmX AI, Inc.
Company typeenum
Private
Founded yearint
2022
Descriptiontext

RhythmX AI (RhythmX AI, Inc.) is a Palo Alto-based, private generative AI company developing a precision care platform for physicians, founded in 2022 and operating as part of SAI Group's enterprise AI portfolio. The company's core product is a precision care platform that consolidates fragmented clinical, social, and lifestyle data into Epic EHR workflows and surfaces guidelines-grounded, hyper-personalized care recommendations at the point of care. The platform is built on SAI Group's proprietary Eureka Gen AI infrastructure and includes named components such as the Patient360 AI Engine, Risk Profiling AI, Disease Progression Trajectories, Hyper-Personalized Care Recommendations, Workflow Intelligence, and Clinician Routing/Patient Orchestration. AI capabilities span generative AI, predictive analytics, recommendation engines, and knowledge retrieval from leading U.S. and international clinical practice guidelines, with inline attribution supporting clinician verification.

The company monetizes through enterprise subscription licensing to health systems. In November 2025, RhythmX AI merged with Get Well (also a SymphonyAI Group company) to form GW RhythmX, an AI-driven personalized care platform integrating precision care and patient engagement across 150+ health systems serving 85 million patients. Combined offerings now span ambulatory precision care and inpatient Smart Room technology, with named enterprise deployments at Presbyterian Healthcare Services (200 primary care clinicians, first full system deployment) and UCI Health's $1.3 billion Irvine campus. Distribution occurs via direct enterprise field sales, Epic EHR embedded workflows, and the Microsoft Dragon Copilot marketplace, where the platform has delivered over 296,000 treatment recommendations with a stated $57M annual economic engine per 200 physicians.

RhythmX AI operates with 11–50 employees under SAI Group, which provides access to a 4,000-person bench (250 data scientists and 1,000 healthcare-dedicated staff) and over $1B in cumulative R&D investment. Leadership includes Founder/CEO Deepthi Bathina, Chairman Romesh Wadhwani, PhD, CRO Tim Kostner, VP of AI Nathan Gnanasambandam, PhD, and VP of Growth Dan Doherty. The company is HIPAA-compliant as a Business Associate and CCPA-compliant, processes PHI under BAAs with healthcare customers, and concentrates on health systems and primary care clinicians as core customer segments.

Short descriptiontext

RhythmX AI is a generative AI-native precision care platform for physicians that surfaces guidelines-grounded, hyper-personalized treatment recommendations inside Epic EHR workflows; it serves health systems and primary care clinicians and now operates as part of GW RhythmX alongside Get Well.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPalo Alto, United States
HQ citystring
Palo Alto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI precision care platform, clinical decision support, healthcare AI platform, EHR workflow integration, patient risk stratification
Industry4 codes
1AI/Analytics for RPM (Risk Stratification, Alerts, Predictive)
CodeHLACAFAMPrimaryYes
2Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management)
CodeHLALAFALPrimaryNo
3Care Pathway Automation & Patient Engagement for RPM (Coaching, Messaging, Scheduling)
CodeHLACAPAMPrimaryNo
4Chronic Care & Remote Patient Monitoring (RPM) Platforms
CodeHLALABAFPrimaryNo
NAICS code2 codes
  • Custom Computer Programming Services541511
  • Computer Systems Design Services541512
SIC code2 codes
  • Services-Computer Programming, Data Processing, Etc.7370
  • Services-Computer Integrated Systems Design7373
Product category
Clinical Decision Support Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Enterprise Healthcare AI Platform Licensing
TypeSubscription Recurring
Description

Subscription-based licensing of precision care AI platform to health systems, with the platform delivering measurable economic impact (up to $57M annually for 200 physicians per Microsoft partnership announcement)

prnewswire.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

RhythmX AI provides a generative AI-native precision care platform for physicians that delivers hyper-personalized care recommendations, patient risk stratification, disease progression predictions, workflow intelligence, and clinician routing/orchestration directly within the EHR workflow. The platform is built on SAI Group's Eureka Gen AI infrastructure, integrates with Epic EHR, and serves health systems across 150+ deployments reaching 85 million patients. Following the November 2025 merger with Get Well, the combined GW RhythmX entity also offers Smart Room Technology for inpatient patient engagement.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 22% reduction in 30-day readmissions
+5 more records
Product overview1 text field

RhythmX AI offers a unified precision care platform combining generative AI, predictive analytics, and workflow intelligence. The core RhythmX AI Precision Care Platform is built on the Eureka Gen AI platform (SAI Group) and integrates multiple AI capabilities including the Patient360 AI Engine for data consolidation, Risk Profiling AI for patient stratification, Disease Progression Trajectories for care insights, Hyper-Personalized Care Recommendations, and Workflow Intelligence. The platform routes patients to optimal clinicians and integrates with Epic EHR. Following the merger with Get Well (November 2025), the combined GW RhythmX entity also includes the Get Well Patient Engagement Solution with Smart Room Technology for inpatient settings.

Product and service2 records
1RhythmX AI Precision Care Platform
CategoryPrecision Care Platform
Description

The world's first native generative AI precision care platform for physicians, providing hyper-personalized interventions and compassionate care at the point of care. Delivers right care to right patient at right time through the right clinician, integrating risk profiling, disease progression predictions, workflow intelligence, and clinician routing within Epic EHR workflows.

2Get Well Smart Room Technology
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-10-17
Description

RhythmX AI integrated its precision care platform into Microsoft Dragon Copilot to provide clinicians with real-time, clinically validated patient data for hyper-personalized treatment. The platform delivered over 296,000 treatment recommendations and validated an economic engine generating up to $57M annually for 200 physicians. This partnership enhances personalized care and clinical workflow efficiency with enterprise-scale AI solutions.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Abridge builds generative AI for clinical documentation and care conversations, competing directly with RhythmX AI's precision care platform for ambient AI-driven clinician workflows within the EHR.

TypeDirect peer
Description

Suki is an AI voice assistant and clinical documentation platform for clinicians, overlapping with RhythmX AI on ambient AI inside the physician workflow but more narrowly focused on documentation and coding.

TypeBroad incumbent
Description

Nuance's Dragon Copilot is both a RhythmX partner and a competing ambient AI surface for clinicians, making it a broad incumbent in AI-driven clinical workflow automation at health systems worldwide.

TypeBroad incumbent
Description

Tempus AI offers AI-driven precision medicine spanning oncology and broader clinical decision support, comparable in scale and ambitions to RhythmX's precision care platform but with a stronger oncology and molecular data footprint.

TypeEmerging player
Description

ConcertAI is a sister company under SAI Group focused on AI for oncology and real-world evidence; it shares the parent data infrastructure and AI tooling with RhythmX, making it the most thematically adjacent SAI Group peer.

TypeDirect peer
Description

Notable applies AI to automate clinical and administrative workflows for health systems, competing with RhythmX AI on workflow intelligence and clinician burden reduction inside the EHR.

TypeDirect peer
Description

Augmedix provides AI-driven medical documentation and ambient scribing for clinicians, directly overlapping with RhythmX AI's clinician-facing precision care and EHR-integrated AI assistant capabilities.

TypeEmerging player
Description

Hippocratic AI builds healthcare-focused LLMs for clinical and patient-facing use cases, comparable to RhythmX AI's generative AI precision care platform in scope of clinical applications and target customer base.

TypeDirect peer
Description

Athelas provides AI-driven healthcare workflow and revenue cycle tools to physician practices and health systems; it competes with RhythmX AI on AI-enabled clinical workflow automation for providers.

TypeDirect peer
Description

DeepScribe is an ambient AI medical scribe platform operating inside the EHR, comparable to RhythmX AI's clinician-centric AI assistant approach for ambulatory and specialty settings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RhythmX AI

Clinical Decision Support Softwarerhythmx.ai

RhythmX AI is a generative AI-native precision care platform for physicians that surfaces guidelines-grounded, hyper-personalized treatment recommendations inside Epic EHR workflows; it serves health systems and primary care clinicians and now operates as part of GW RhythmX alongside Get Well.

What RhythmX AI does

RhythmX AI (RhythmX AI, Inc.) is a Palo Alto-based, private generative AI company developing a precision care platform for physicians, founded in 2022 and operating as part of SAI Group's enterprise AI portfolio. The company's core product is a precision care platform that consolidates fragmented clinical, social, and lifestyle data into Epic EHR workflows and surfaces guidelines-grounded, hyper-personalized care recommendations at the point of care. The platform is built on SAI Group's proprietary Eureka Gen AI infrastructure and includes named components such as the Patient360 AI Engine, Risk Profiling AI, Disease Progression Trajectories, Hyper-Personalized Care Recommendations, Workflow Intelligence, and Clinician Routing/Patient Orchestration. AI capabilities span generative AI, predictive analytics, recommendation engines, and knowledge retrieval from leading U.S. and international clinical practice guidelines, with inline attribution supporting clinician verification.

The company monetizes through enterprise subscription licensing to health systems. In November 2025, RhythmX AI merged with Get Well (also a SymphonyAI Group company) to form GW RhythmX, an AI-driven personalized care platform integrating precision care and patient engagement across 150+ health systems serving 85 million patients. Combined offerings now span ambulatory precision care and inpatient Smart Room technology, with named enterprise deployments at Presbyterian Healthcare Services (200 primary care clinicians, first full system deployment) and UCI Health's $1.3 billion Irvine campus. Distribution occurs via direct enterprise field sales, Epic EHR embedded workflows, and the Microsoft Dragon Copilot marketplace, where the platform has delivered over 296,000 treatment recommendations with a stated $57M annual economic engine per 200 physicians.

RhythmX AI operates with 11–50 employees under SAI Group, which provides access to a 4,000-person bench (250 data scientists and 1,000 healthcare-dedicated staff) and over $1B in cumulative R&D investment. Leadership includes Founder/CEO Deepthi Bathina, Chairman Romesh Wadhwani, PhD, CRO Tim Kostner, VP of AI Nathan Gnanasambandam, PhD, and VP of Growth Dan Doherty. The company is HIPAA-compliant as a Business Associate and CCPA-compliant, processes PHI under BAAs with healthcare customers, and concentrates on health systems and primary care clinicians as core customer segments.

RhythmX AI firmographics

Firmographics
Name
RhythmX AI
Legal name
RhythmX AI, Inc.
Website
https://rhythmx.ai
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
RhythmX AI is a generative AI-native precision care platform for physicians that surfaces guidelines-grounded, hyper-personalized treatment recommendations inside Epic EHR workflows; it serves health systems and primary care clinicians and now operates as part of GW RhythmX alongside Get Well.
Ownership category
akta.pro rank

RhythmX AI industry classification

Industry
Product category
Clinical Decision Support Software
NAICS
Custom Computer Programming Services (541511), Computer Systems Design Services (541512)
SIC
Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Integrated Systems Design (7373)
akta.pro primary industry
AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM)
akta.pro secondary industries
Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management) (HLALAFAL), Care Pathway Automation & Patient Engagement for RPM (Coaching, Messaging, Scheduling) (HLACAPAM), Chronic Care & Remote Patient Monitoring (RPM) Platforms (HLALABAF)

Keywords

  • AI precision care platform
  • Clinical decision support
  • Healthcare AI platform
  • EHR workflow integration
  • Patient risk stratification

Where RhythmX AI is headquartered

Location

Headquarters

HQ city
Palo Alto
HQ country
United States
HQ region
North America

Offices1 record

Markets served

RhythmX AI business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Enterprise Healthcare AI Platform Licensing: Subscription-based licensing of precision care AI platform to health systems, with the platform delivering measurable economic impact (up to $57M annually for 200 physicians per Microsoft partnership announcement)

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

RhythmX AI product offering

Product offering

Core offering

RhythmX AI provides a generative AI-native precision care platform for physicians that delivers hyper-personalized care recommendations, patient risk stratification, disease progression predictions, workflow intelligence, and clinician routing/orchestration directly within the EHR workflow. The platform is built on SAI Group's Eureka Gen AI infrastructure, integrates with Epic EHR, and serves health systems across 150+ deployments reaching 85 million patients. Following the November 2025 merger with Get Well, the combined GW RhythmX entity also offers Smart Room Technology for inpatient patient engagement.

Product overview

RhythmX AI offers a unified precision care platform combining generative AI, predictive analytics, and workflow intelligence. The core RhythmX AI Precision Care Platform is built on the Eureka Gen AI platform (SAI Group) and integrates multiple AI capabilities including the Patient360 AI Engine for data consolidation, Risk Profiling AI for patient stratification, Disease Progression Trajectories for care insights, Hyper-Personalized Care Recommendations, and Workflow Intelligence. The platform routes patients to optimal clinicians and integrates with Epic EHR. Following the merger with Get Well (November 2025), the combined GW RhythmX entity also includes the Get Well Patient Engagement Solution with Smart Room Technology for inpatient settings.

Differentiator

Problem solved

Functional benefit

Products and services

  • RhythmX AI Precision Care Platform The world's first native generative AI precision care platform for physicians, providing hyper-personalized interventions and compassionate care at the point of care. Delivers right care to right patient at right time through the right clinician, integrating risk profiling, disease progression predictions, workflow intelligence, and clinician routing within Epic EHR workflows.
  • Get Well Smart Room Technology

Quantifiable outcome

  • 22% reduction in 30-day readmissions
  • +5 more outcomes

Companies that use RhythmX AI

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles1 record

RhythmX AI technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature6 records

RhythmX AI partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • MicrosoftcoreTechnology or Integration · 17 October 2025RhythmX AI integrated its precision care platform into Microsoft Dragon Copilot to provide clinicians with real-time, clinically validated patient data for hyper-personalized treatment. The platform delivered over 296,000 treatment recommendations and validated an economic engine generating up to $57M annually for 200 physicians. This partnership enhances personalized care and clinical workflow efficiency with enterprise-scale AI solutions.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

RhythmX AI competitors and assessment

Company assessment

Direct peers

  • Abridge: Abridge builds generative AI for clinical documentation and care conversations, competing directly with RhythmX AI's precision care platform for ambient AI-driven clinician workflows within the EHR.
  • Suki AI: Suki is an AI voice assistant and clinical documentation platform for clinicians, overlapping with RhythmX AI on ambient AI inside the physician workflow but more narrowly focused on documentation and coding.
  • Notable: Notable applies AI to automate clinical and administrative workflows for health systems, competing with RhythmX AI on workflow intelligence and clinician burden reduction inside the EHR.
  • Augmedix: Augmedix provides AI-driven medical documentation and ambient scribing for clinicians, directly overlapping with RhythmX AI's clinician-facing precision care and EHR-integrated AI assistant capabilities.
  • Athelas: Athelas provides AI-driven healthcare workflow and revenue cycle tools to physician practices and health systems; it competes with RhythmX AI on AI-enabled clinical workflow automation for providers.
  • DeepScribe: DeepScribe is an ambient AI medical scribe platform operating inside the EHR, comparable to RhythmX AI's clinician-centric AI assistant approach for ambulatory and specialty settings.

Broad incumbents

  • Microsoft Nuance (DAX / Dragon Copilot): Nuance's Dragon Copilot is both a RhythmX partner and a competing ambient AI surface for clinicians, making it a broad incumbent in AI-driven clinical workflow automation at health systems worldwide.
  • Tempus AI: Tempus AI offers AI-driven precision medicine spanning oncology and broader clinical decision support, comparable in scale and ambitions to RhythmX's precision care platform but with a stronger oncology and molecular data footprint.

Emerging players

  • ConcertAI: ConcertAI is a sister company under SAI Group focused on AI for oncology and real-world evidence; it shares the parent data infrastructure and AI tooling with RhythmX, making it the most thematically adjacent SAI Group peer.
  • Hippocratic AI: Hippocratic AI builds healthcare-focused LLMs for clinical and patient-facing use cases, comparable to RhythmX AI's generative AI precision care platform in scope of clinical applications and target customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

RhythmX AI social profiles

Digital presence

RhythmX AI compliance and trust

Trust signal

Compliance3 records

RhythmX AI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RhythmX AI leadership team

Management profile

Number of profiles

Profiles10 records

RhythmX AI funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RhythmX AI M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RhythmX AI

What does RhythmX AI do?

RhythmX AI provides a generative AI-native precision care platform for physicians that delivers hyper-personalized care recommendations, patient risk stratification, disease progression predictions, workflow intelligence, and clinician routing/orchestration directly within the EHR workflow. The platform is built on SAI Group's Eureka Gen AI infrastructure, integrates with Epic EHR, and serves health systems across 150+ deployments reaching 85 million patients. Following the November 2025 merger with Get Well, the combined GW RhythmX entity also offers Smart Room Technology for inpatient patient engagement.

Is RhythmX AI a public or private company?

RhythmX AI is a private company. It is classified as corporate owned and is currently operating.

When was RhythmX AI founded?

RhythmX AI was founded in 2022. It employs 11 to 50 people.

Where is RhythmX AI based?

RhythmX AI is headquartered in Palo Alto, United States, in the North America region.

How does RhythmX AI make money?

One revenue line is on record: enterprise Healthcare AI Platform Licensing.

Who are RhythmX AI's main competitors?

Direct peers on record are Abridge, Suki AI, Notable, Augmedix, Athelas and DeepScribe. Broad incumbents are Microsoft Nuance (DAX / Dragon Copilot) and Tempus AI. Emerging players are ConcertAI and Hippocratic AI.

Does RhythmX AI have an API?

No public API is recorded for RhythmX AI.

What industry is RhythmX AI in?

RhythmX AI's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACAFAM, AI/Analytics for RPM (Risk Stratification, Alerts, Predictive), with a secondary code of HLALAFAL, Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management). Its NAICS code is 541511 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AijournGW RhythmX Now Available in the Microsoft MarketplaceGW RhythmX announced the availability of its RhythmX Pulse clinical decision-support tool on Microsoft Marketplace, enabling health systems to deploy the AI-powered solution through existing Microsoft infrastructure. RhythmX Pulse integrates with Dragon Copilot to provide real-time, patient-specific recommendations by analyzing medical history, clinical guidelines, payer rules, and formulary data during patient encounters. Sentara Health endorsed the integration, marking the first phase of a broader roadmap between GW RhythmX and Microsoft for extended care-coordination capabilities.PR NewswireGW RhythmX Now Available in the Microsoft MarketplaceGW RhythmX announced RhythmX Pulse is now available on Microsoft Marketplace, allowing customers to deploy it with Azure integration. The tool uses Dragon Copilot to surface real-time, patient-specific clinical recommendations based on medical history, guidelines, and payer rules. It is the first phase of a broader roadmap extending recommendations across the care journey.PR NewswireGet Well, a leader in patient engagement software, and RhythmX AI, a leader in AI-powered precision care, will combine to form GW RhythmX to usher in the next generation of precision careGet Well and RhythmX AI have combined to form GW RhythmX, a new entity backed by SymphonyAI Group that aims to integrate AI-powered precision care with patient engagement solutions. The combined company will serve over 150 health systems and is led by RhythmX AI Founder and CEO Deepthi Bathina.PR NewswireRhythmX AI Collaborates with Microsoft to Deliver Hyper-Personalized Care Through Dragon CopilotRhythmX AI announced a collaboration with Microsoft to integrate its Enterprise Precision Care Platform into Microsoft's Dragon Copilot, equipping clinicians with real-time whole-patient intelligence within existing workflows. The platform unifies more than eight patient data sources and has delivered 296,000+ hyper-personalized treatment recommendations while validating a potential $57M in incremental annual revenue for just 200 primary care providers. The partnership aims to enable health systems to scale hyper-personalized care and achieve measurable ROI in both fee-for-service and value-based care settings.PR NewswireRhythmX AI Founder and CEO Deepthi Bathina to Speak on Generative AI in Healthcare at CHIME 23RhythmX AI founder and CEO Deepthi Bathina will serve as a panelist at the CHIME Fall Forum in Phoenix to discuss generative AI applications in healthcare. The event follows the company's recent $50 million funding announcement by SAIGroup, with Bathina joining industry leaders from Microsoft Health and Children's Hospitals of Philadelphia and Seattle to evaluate AI case studies.PR NewswireNew Generative AI-Native Health Company RhythmX AI Announces Precision Care Platform for Doctors to Deliver Hyper-Personalized Care to the Right Patient at the Right TimeSAIGroup announced the launch and $50 million initial funding of RhythmX AI, a generative AI-native precision care company designed to help doctors deliver hyper-personalized patient care through advanced AI capabilities and predictive algorithms. The platform addresses the approximately $4 trillion spent annually on chronic conditions in the U.S., exacerbated by physician shortages and increasing demands for integrated care delivery. RhythmX AI, chaired by AI entrepreneur Dr. Romesh Wadhwani and led by CEO Deepthi Bathina, will leverage SAIGroup's Eureka AI platform and longitudinal data covering 300 million patients, 4.4 billion annual claims, and over 1.8 million healthcare professionals.